Trial ID: | L0919 |
Source ID: | IRCT201206094105N8
|
Associated Drug: |
Coenzyme Q10
|
Title: |
The effect of coenzyme Q10 on serum concentrations of adipokines and Malondialdehyde in non-alcoholic fatty liver disease
|
Acronym: |
--
|
Status: |
Not Recruiting
|
Study Results: |
No Results Available
|
Results: |
--
|
Conditions: |
Non-alcoholic fatty liver disease. <br>Other diseases of liver;Other diseases of liver
|
Interventions: |
Intervention 1: One 100 milligram capsule each day for 4 weeks. Intervention 2: One capsule containing starch each day for 4 weeks.;Treatment - Drugs;Placebo;One 100 milligram capsule each day for 4 weeks;One capsule containing starch each day for 4 weeks
|
Outcome Measures: |
Chemerin. Timepoint: At baseine and after 4 weeks of intervention. Method of measurement: ELIZA.;Vaspin. Timepoint: At baseine and after 4 weeks of intervention. Method of measurement: ELIZA.;Malondialdehyde. Timepoint: At baseine and after 4 weeks of intervention. Method of measurement: Spectrophotometry.Food intake. Timepoint: At baseine and after 4 weeks of intervention. Method of measurement: dietary record questionnaire.;Body Mass Index. Timepoint: At baseine and after 4 weeks of intervention. Method of measurement: Scales and meters.
|
Sponsor/Collaborators: |
Vice chancellor for Research, Tabriz University of Medical Sciences
|
Gender: |
All
|
Age: |
20 years65 years
|
Phases: |
Phase 2
|
Enrollment: |
44
|
Study Type: |
interventional
|
Study Designs: |
Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment.
|
Start Date: |
15/06/2013
|
Completion Date: |
--
|
Results First Posted: |
--
|
Last Update Posted: |
22 February 2018
|
Locations: |
Iran (Islamic Republic of)
|
URL: |
http://en.irct.ir/trial/4305
|